These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 27639891)

  • 1. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
    Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
    Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
    Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
    Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.
    Eekers DBP; Roelofs E; Cubillos-Mesías M; Niël C; Smeenk RJ; Hoeben A; Minken AWH; Granzier M; Janssens GO; Kaanders JHAM; Lambin P; Troost EGC
    Acta Oncol; 2019 Jan; 58(1):57-65. PubMed ID: 30474448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer.
    Buciuman N; Dasu A; Marcu LG
    Phys Med; 2024 Jul; 123():103427. PubMed ID: 38959576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
    Chi A; Lin LC; Wen S; Yan H; Hsi WC
    Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ART for head and neck patients: On the difference between VMAT and IMPT.
    Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D
    Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.
    Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C
    J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
    Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
    Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
    Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
    Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there room for combined modality treatments? Dosimetric comparison of boost strategies for advanced head and neck and prostate cancer.
    Góra J; Hopfgartner J; Kuess P; Paskeviciute B; Georg D
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i97-112. PubMed ID: 23824134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers.
    Yang Z; Zhang X; Wang X; Zhu XR; Gunn B; Frank SJ; Chang Y; Li Q; Yang K; Wu G; Liao L; Li Y; Chen M; Li H
    Radiother Oncol; 2020 Jan; 142():124-132. PubMed ID: 31564553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.
    Poel R; Stuessi Lobmaier A; Andratschke N; Unkelbach J; Tanadini-Lang S; Guckenberger M; Foerster R
    Br J Radiol; 2019 Aug; 92(1100):20190113. PubMed ID: 31264474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy.
    Stuschke M; Kaiser A; Abu-Jawad J; Pöttgen C; Levegrün S; Farr J
    Radiat Oncol; 2013 Apr; 8():93. PubMed ID: 23601204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy.
    Yamada M; Sato H; Ieko Y; Miyasaka Y; Kanai T; Yano N; Ono T; Akamatsu H; Harada M; Ichikawa M; Teranishi Y; Kikuchi Y; Nemoto K
    Radiat Oncol; 2019 Nov; 14(1):207. PubMed ID: 31752932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.
    Stromberger C; Cozzi L; Budach V; Fogliata A; Ghadjar P; Wlodarczyk W; Jamil B; Raguse JD; Böttcher A; Marnitz S
    Strahlenther Onkol; 2016 Apr; 192(4):232-9. PubMed ID: 26852243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional image-guided dose escalation in gliomas using of state-of-the-art photon vs. proton therapy.
    Holm AIS; Petersen JBB; Muren LP; Seiersen K; Borghammer P; Lukacova S
    Acta Oncol; 2017 Jun; 56(6):826-831. PubMed ID: 28464742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.